| abstract |
REFERRING TO A COMPOUND OF FORMULA (I), WHERE ---- IS A CARBON-CARBON SINGLE LINK OR A CARBON-CARBON DOUBLE LINK; R1 IS H, -CH3, PROTECTING GROUP OF N; R2 IS H, HALO, -OH, -CH3, CYCLOPROPYL, AMONG OTHERS; R3 IS H, OXO, HALO, METHYL; R4 IS HALO, ALKYL, NO2, AZIDO, AMONG OTHERS; R5 IS H, -OH, ALKYL, ALKYLOXY, AMONG OTHERS; R6 IS 2-RING FUSED CARBOYCLYL OR 2-RING FUSED HETERO CYCLYL, AMONG OTHERS; L IS A LINK. SAID COMPOUND HAS AN X-RAY DIFFRACTION PATTERN OF POWDERS EXPRESSED IN DEGREES 2 TETA OF 8.3 + -0.2; 9.7 + -0.2; 10.5 + -0.2, AMONG OTHERS. A PREFERRED COMPOUND IS N- (6- (3-TER-BUTYL-5- (2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1 (2H) IL) 2-METOXYPHENIL) NAPHTHALEN-2-IL) METANSULPHONAMIDE. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION THAT INCLUDES THE CRYSTAL FORM AND TO A PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITION WHICH IS USEFUL FOR THE TREATMENT OF HEPATITIS C |